SCHEMBL31542084

SCHEMBL31542084

COC(=O)c1ccc(Cc2nc3ccccc3c(=O)n2-c2ccc(OC)cc2)cc1

nearest known ligand 0.78

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.78
POLB P06746 1/20 0.63
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
CYP1A2 P05177 1/20 0.62
CYP3A4 P08684 1/20 0.62
CYP2D6 P10635 1/20 0.62
CYP2C9 P11712 1/20 0.62
CYP2C19 P33261 1/20 0.62
PDE10A Q9Y233 7/20 0.60
NPC1 O15118 1/20 0.59
RAB9A P51151 1/20 0.59
GAA P10253 1/20 0.59
BLM P54132 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
HTR7 P34969 1/20 0.53
LMNA P02545 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31542069 0.90 ALDH1A1 (0.75) ALDH1A1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL31542082 0.90 POLB (0.63) ALDH1A1POLBMEN1KMT2ACYP1A2
SCHEMBL449655 0.86 POLB (0.61) ALDH1A1POLBMEN1KMT2ACYP1A2
SCHEMBL31542077 0.82 ALDH1A1 (0.57) ALDH1A1POLBMEN1KMT2ACYP1A2
SCHEMBL31542083 0.82 POLB (0.56) ALDH1A1POLBMEN1KMT2ANPC1
SCHEMBL449634 0.81 ALDH1A1 (0.64) ALDH1A1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL7014792 0.81 ALDH1A1 (0.74) ALDH1A1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL31542073 0.81 ALDH1A1 (0.69) ALDH1A1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL453594 0.80 ALDH1A1 (0.76) ALDH1A1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL4958333 0.80 LMNA (0.73) ALDH1A1POLBMEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4622964-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION Gilva Therapeutics Co., Ltd. (TW) 2025-10-01 EP disclosed
WO-2025085669-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION GILVA THERAPEUTICS CO., LTD. (CN) 2025-04-24 WO disclosed